Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Milestone Scientific, Inc. MLSS

Healthcare  —  Medical Instruments & Supplies
0.41 0.00 0.00% as of 25 Sep
Market cap
$37.2M
P/E
0.0×
Cash Flow Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Milestone Scientific, Inc. (MLSS) Business Profile

Updated before January 2025

Company Overview

Milestone Scientific, Inc. (MLSS) is a medical technology company that specializes in innovative injection and drug delivery systems. Founded in 1989, the company is headquartered in Roseland, New Jersey, USA. Milestone Scientific has been at the forefront of developing advanced, computer-controlled drug delivery systems that aim to improve patient comfort and safety. The company’s leadership team includes Leonard Osser, who serves as the Interim Chief Executive Officer, and Joseph D’Agostino, the Chief Financial Officer. Over the years, Milestone Scientific has established itself as a pioneer in the medical and dental technology sectors, leveraging its patented CompuFlo® technology to revolutionize traditional injection methods.

Core Business Segments

Milestone Scientific operates primarily in two core business segments: Dental and Medical.

Dental Segment

The dental segment is one of the company’s foundational business areas. Milestone Scientific’s flagship product in this category is the Wand® STA (Single Tooth Anesthesia) System. This computer-controlled local anesthesia delivery system is designed to provide painless injections, significantly enhancing patient comfort and reducing anxiety. The Wand® STA is widely used by dental professionals globally and has become a preferred choice for procedures requiring precise and minimally invasive anesthesia delivery.

Medical Segment

In the medical segment, Milestone Scientific focuses on developing and commercializing innovative drug delivery systems for various medical applications. The company’s key product in this segment is the CompuFlo® Epidural System, which uses dynamic pressure sensing technology to provide real-time feedback during epidural procedures. This system enhances the accuracy and safety of epidural injections, reducing the risk of complications. Additionally, Milestone Scientific is exploring applications of its technology in other medical fields, such as cosmetic medicine and orthopedics.

Business Model

Milestone Scientific’s business model revolves around the development, manufacturing, and commercialization of its patented drug delivery systems. The company generates revenue through the sale of its devices and disposable components, such as needles and cartridges, which are required for each procedure. This razor-and-blade model ensures a recurring revenue stream as customers continue to purchase consumables for their devices. Milestone Scientific also collaborates with distributors and partners to expand its market reach and drive adoption of its technology in both dental and medical sectors.

Strategic Direction

Milestone Scientific is committed to expanding its presence in the medical and dental markets while exploring new applications for its technology. The company’s strategic priorities include:

  • Market Expansion: Increasing adoption of the Wand® STA and CompuFlo® Epidural System in existing and new markets.
  • Product Innovation: Developing new products and enhancing existing ones to address unmet needs in drug delivery and patient care.
  • Sustainability Goals: Implementing environmentally friendly practices in manufacturing and product design to reduce waste and carbon footprint.
  • Diversification: Exploring opportunities in emerging fields such as cosmetic medicine, orthopedics, and veterinary applications.

Competitive Landscape

Milestone Scientific operates in a competitive landscape that includes both established players and emerging companies in the medical and dental technology sectors. Key competitors include:

  • Dental Segment: Companies like Dentsply Sirona and Henry Schein, which offer a wide range of dental products and technologies.
  • Medical Segment: Firms such as B. Braun and Smiths Medical, which provide advanced drug delivery systems and related technologies.

Milestone Scientific differentiates itself through its patented CompuFlo® technology, which offers unique advantages in terms of precision, safety, and patient comfort.

Risk Factors

Milestone Scientific faces several risks that could impact its business operations and financial performance:

  • Market Dependence: The company relies heavily on the success of its Wand® STA and CompuFlo® systems. Any decline in demand for these products could adversely affect revenue.
  • Regulatory Challenges: Compliance with stringent regulatory requirements in different countries can be time-consuming and costly.
  • Supply Chain Disruptions: Dependence on third-party manufacturers and suppliers exposes the company to risks related to production delays and cost fluctuations.
  • Competition: Intense competition from established players and new entrants could impact market share and pricing power.

Recent Developments

Milestone Scientific has made significant strides in recent years to strengthen its market position and drive innovation:

  • Product Launches: The company recently introduced enhancements to its CompuFlo® Epidural System, improving usability and performance.
  • Strategic Partnerships: Milestone Scientific has entered into distribution agreements with leading medical and dental distributors to expand its global reach.
  • COVID-19 Impact: The pandemic highlighted the importance of safe and precise drug delivery systems, boosting demand for the company’s products in certain markets.

Investment Considerations

Investors considering Milestone Scientific should weigh the following strengths and risks:

Strengths

  • Innovative Technology: Patented CompuFlo® technology provides a competitive edge in precision drug delivery.
  • Recurring Revenue Model: The sale of disposable components ensures a steady revenue stream.
  • Growth Potential: Expanding applications for its technology in medical and dental fields offer significant growth opportunities.

Risks

  • Market Concentration: Heavy reliance on a few key products could pose challenges if demand declines.
  • Regulatory Hurdles: Navigating complex regulatory environments may delay product launches and increase costs.
  • Competition: Intense competition from established players could impact profitability.

Conclusion

Milestone Scientific, Inc. is a pioneering company in the medical and dental technology sectors, known for its innovative drug delivery systems. With a strong focus on patient safety and comfort, the company has carved out a niche in the market. While challenges such as regulatory hurdles and competition exist, Milestone Scientific’s patented technology and strategic initiatives position it well for future growth. As the company continues to expand its product portfolio and explore new markets, it remains an attractive option for investors seeking exposure to the medical technology sector.